Arvid Engström

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

Diabetes care

European heart journal. Cardiovascular pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Arvid Engström, Jonas Söderling, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Björn Pasternak, Peter Ueda
Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study. European heart journal. Cardiovascular pharmacotherapy 10 (5) (2024)
Arvid Engström, Jonas Söderling, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Björn Pasternak, Peter Ueda
Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: scandinavian cohort study. European heart journal. Cardiovascular pharmacotherapy (2024)
Arvid Engström, Viktor Wintzell, Mads Melbye, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Henrik Svanström, Björn Pasternak, Peter Ueda
Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Diabetes care 46 (2) (2023)
Arvid Engström, Viktor Wintzell, Mads Melbye, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Henrik Svanström, Björn Pasternak, Peter Ueda
Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Diabetes care 46 (2) (2023)
Arvid Engström, Viktor Wintzell, Mads Melbye, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Henrik Svanström, Björn Pasternak, Peter Ueda
Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Diabetes care 46 (2) (2023)
Arvid Engström, Viktor Wintzell, Mads Melbye, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Kristian Hveem, Christian Jonasson, Henrik Svanström, Björn Pasternak, Peter Ueda
Sodium-Glucose Cotransporter 2 Inhibitor Treatment and Risk of Atrial Fibrillation: Scandinavian Cohort Study. Diabetes care (2022)

Arvid Engström.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Arvid Engström